BioSpace News Archive

Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT) , a late stage theranostic company advancing therapeutic options for sepsis and septic shock, as well as commercializing a new proprietary platform targeting the renal replacement therapy market through its wholly owned subsidiary Dialco Medical Inc. ( “ Dialco ” ), today announced the details for the Company’s upcoming Virtual Investor Day, scheduled to be held on Friday, December 4, 2

MCI Diagnostic Center, a Service-Disabled Veteran Owned small business that offers national laboratory testing and diagnostics in all 50 states, officially introduced the Dallas community to its new state-of-the-art laboratory and staff.

Genetron Health Provides Update on HCCscreen™ for Liver Cancer Early Screening in China HCCscreen TM was selected by the National Cancer Center and the Wuxi municipal government for use in the “Liver Cancer Early Screening Comprehensive Prevention and Control Project”, a public health initiative Establishes joint venture with Wuxi municipal government; Expects the commercialization and revenues of HCCscreen TM to accelerate in China

Hologic, Inc. (Nasdaq: HOLX) will virtually showcase its extensive portfolio of breast and skeletal health products, including screening, surgical, interventional, ultrasound and skeletal solutions, at the 106 th Scientific Assembly and Annual Meeting of the Radiological S

Cassava Sciences, Inc. (Nasdaq: SAVA) today announced that the World Health Organization (WHO) advised the United States Adopted Names Council (USAN) to modify the chemical name of the Company’s lead drug candidate to ‘simufilam.’ This change was advised by WHO to avoid a potential trademark conflict with a drug marketed in the Far East. USAN has accepted WHO’s advice. Future references to Cassava Sciences’ lead drug candidate for Alzheimer’s

Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the companys Board of Directors has approved a reverse stock split of its shares of common stock at a ratio of 1 for 25. The Reverse Stock Split will become effective at 12:01 a.m. Eastern time on November 30, 2020 and the Companys common stock will open for tr

Live demonstration now scheduled for 11:30am EST on Thursday, December 3 Company to host investor webinar following the live demonstration at 2:30pm EST on the same day NEVE ILAN, Israel, Nov. 27, 2020 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“ Nanox ” or the “ Company ”), an innovative medical imaging technology company, announced today that the Company will host a live demonstration that will showcase the Nanox digital x-ray source tube and a range of 2D and 3D imag

– R&D activities focused on advancing the development of innovative delivery systems and yeast beta glucan as a potential inhalable therapeutic for COVID-19 – – Q3 2020 sales of $ 3,4 7 6,000 compared to $ 2,908 ,000 for Q3 2019, representing a 20 % increase – – Net profit of $ 192 ,000 for Q 3 2020 vs. net loss of $ 104 ,000 for Q 3 2019 – – Cash generated from operations of $ 4,777 ,000 in 2020 vs . $ 1,321 ,000 in 2019 – –

Overjet Inc, the leading provider of artificial intelligence (AI) for the dental community, was selected by AEGIS to share a curated series on how AI is transforming dentistry. The series will appear in Compendium in 2021

Calliditas Therapeutics AB (publ.) publishes the nomination committee’s composition for the AGM in 2021. The nomination committee, which is appointed in accordance with the principles adopted by the extraordinary general meeting on September 14, 2017 , consists of: · Patrick Sobocki, appointed by Stiftelsen Industrifonden